Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119900097 | 11990009 | 7 | F | 201601 | 20160722 | 20160202 | 20160726 | EXP | US-PFIZER INC-2016048361 | PFIZER | 76.00 | YR | F | Y | 81.18000 | KG | 20160726 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119900097 | 11990009 | 1 | PS | REVATIO | SILDENAFIL CITRATE | 1 | 20 MG, 2X/DAY | 21845 | 20 | MG | FILM-COATED TABLET | BID | |||||||
| 119900097 | 11990009 | 2 | SS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 20 MG, 2X/DAY | 21845 | 20 | MG | FILM-COATED TABLET | BID | ||||||
| 119900097 | 11990009 | 3 | SS | REVATIO | SILDENAFIL CITRATE | 1 | 20 MG, 2X/DAY | A527301 | 21845 | 20 | MG | FILM-COATED TABLET | BID | ||||||
| 119900097 | 11990009 | 4 | C | CARVEDILOL. | CARVEDILOL | 1 | 6.25 MG, 2X/DAY | 0 | 6.25 | MG | BID | ||||||||
| 119900097 | 11990009 | 5 | C | BABY ASPIRIN | ASPIRIN | 1 | UNK UNK, 1X/DAY | 0 | QD | ||||||||||
| 119900097 | 11990009 | 6 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | 25 MG, 3X/DAY | 0 | 25 | MG | TID | ||||||||
| 119900097 | 11990009 | 7 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 1000 MG, 2X/DAY (PROBABLY IN HER 50'S WHEN SHE STARTED THIS) | 0 | 1000 | MG | TABLET | BID | |||||||
| 119900097 | 11990009 | 8 | C | GLYBURIDE. | GLYBURIDE | 1 | 5 MG, 1X/DAY | 0 | 5 | MG | QD | ||||||||
| 119900097 | 11990009 | 9 | C | BUMETANIDE. | BUMETANIDE | 1 | 2 MG, 2X/DAY | 0 | 2 | MG | BID | ||||||||
| 119900097 | 11990009 | 10 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 100 MG, 2X/DAY | 0 | 100 | MG | BID | ||||||||
| 119900097 | 11990009 | 11 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 100 MG, UNK | 0 | 100 | MG | |||||||||
| 119900097 | 11990009 | 12 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 200 MG, 1X/DAY | 0 | 200 | MG | QD | ||||||||
| 119900097 | 11990009 | 13 | C | ASPIRIN. | ASPIRIN | 1 | 81 MG, 1X/DAY | 0 | 81 | MG | QD | ||||||||
| 119900097 | 11990009 | 14 | C | GLIPIZIDE. | GLIPIZIDE | 1 | 5 MG, UNK | 0 | 5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119900097 | 11990009 | 1 | Pulmonary hypertension |
| 119900097 | 11990009 | 4 | Cardiac disorder |
| 119900097 | 11990009 | 6 | Blood pressure abnormal |
| 119900097 | 11990009 | 7 | Diabetes mellitus |
| 119900097 | 11990009 | 8 | Diabetes mellitus |
| 119900097 | 11990009 | 9 | Fluid imbalance |
| 119900097 | 11990009 | 10 | Blood uric acid |
| 119900097 | 11990009 | 12 | Thyroid disorder |
| 119900097 | 11990009 | 13 | Cardiac disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119900097 | 11990009 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119900097 | 11990009 | Arrhythmia | |
| 119900097 | 11990009 | Blood pressure increased | |
| 119900097 | 11990009 | Diarrhoea | |
| 119900097 | 11990009 | Heart rate increased | |
| 119900097 | 11990009 | Oxygen saturation decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119900097 | 11990009 | 1 | 2014 | 0 | ||
| 119900097 | 11990009 | 2 | 201401 | 0 | ||
| 119900097 | 11990009 | 3 | 20140416 | 0 | ||
| 119900097 | 11990009 | 11 | 20160105 | 0 |